Stock Updates

How has Bristol-Myers Squibb Company:(NYSE:BMY) performed recently?

Bristol-Myers Squibb Company (NYSE: BMY) is a large market cap stock with a market cap of 91461.5. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 32.06, a forward P/E of 18.29 and EPS of 1.71. At a stock price of 54.79 (-0.07%) it has a dividend yield of 2.77%.

EPS growth for the last five years have been -12.20%, more recently this last year it has grown by -22.30%. The next year growth is going to be about 14.14% and more long-term 19.59% after five years. EPS growth quarter over quarter is 990.60%. Sales growth for the past five years have been -3.20% and sales growth quarter over quarter is 17.00%.

For performance, Bristol-Myers Squibb Company the past week has seen a gain of 0.14%. For the last month performance for Bristol-Myers Squibb Company is -3.14%. While the last quarter is -25.53% and half year, -16.32%. Finally for the year, performance is -6.32%.

The 52-week high for Bristol-Myers Squibb Company, is at -28.95%, and for the 52-week low it comes to a value of 2.30%. The 20-day simple moving average is -9.15% and -16.57% for the 200-day simple moving average.

Volatility for the week is at 1.79%, and for the month it is 1.74%. Bristol-Myers Squibb Company, has a target price of 67.35.

In terms of debt, long term debt/equity is 0.44, and for total debt/equity Bristol-Myers Squibb Company has 0.45. The gross margin is 75.70%, while operating margin is 20.80%, the profit margin is 16.30%. The current ratio is 1.6 and the quick ratio is 1.4.

Insider ownership is at 0.10%, with instituitional ownership at 74.30%. Bristol-Myers Squibb Company has a payout ratio of 87.80%. With the total shares outstanding coming to 1669.31. The shares float is 1504.56, with the float short at 0.93%, with short ratio coming to 1.18.

In terms of returns, the return on assets see Bristol-Myers Squibb Company, get 9.00%, with its returns on investment at 4.60%. Return on equity is 19.60%. So will the investors see the target price of 67.35, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment